|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 22/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 30/09/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 31/03/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/12/2014 | |
Haruhisa Inada
BRD | Director/Board Member | - | 29/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 30/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.38% | -3.77% | -8.73% | -29.00% | 240B | ||
| +0.01% | -4.76% | -41.06% | -56.92% | 41.78B | ||
| +1.33% | -2.10% | -36.09% | -47.54% | 21.53B | ||
| +0.31% | -4.55% | -30.54% | -63.15% | 18.85B | ||
| -1.56% | -0.07% | +15.28% | +51.67% | 11.47B | ||
| -0.43% | -4.62% | -43.27% | -71.17% | 8.9B | ||
| -0.75% | -2.64% | -11.11% | -49.72% | 8.17B | ||
| +1.33% | -0.28% | -34.60% | -64.70% | 6.66B | ||
| +1.52% | +5.95% | -24.48% | -49.88% | 5.48B | ||
| Average | +0.24% | -2.52% | -23.84% | -42.27% | 40.29B | |
| Weighted average by Cap. | +0.32% | -3.15% | -16.06% | -35.01% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















